Marsh stock drops as $425 million Greensill litigation charge overshadows Q1 results
Marsh (MRSH) is sliding after reporting Q1 2026 results that included a $425 million litigation-related charge tied to the Greensill matter. Even with revenue growth, the legal hit pressured GAAP profitability and refocused investors on exposure to further legal costs.
1. What’s moving the stock
Marsh shares are lower today as investors digest first-quarter 2026 earnings released April 16, which included a large litigation-related charge connected to the Greensill Capital matter. The charge weighed on GAAP profitability and is driving renewed concern about the ultimate cost and timing of resolving the dispute.
2. Key numbers and the core investor issue
The company recorded a $425 million charge tied to Greensill-related litigation, which reduced reported results despite otherwise solid operating performance. The market reaction suggests investors are re-pricing the stock for higher legal-risk uncertainty and potential follow-on expenses, even as underlying revenue trends held up.
3. What to watch next
Focus is shifting to whether additional charges are possible, how quickly the litigation can be resolved, and whether management provides more detail on expected cash impact. Investors will also watch for any commentary on insurance pricing trends and organic growth as the near-term narrative moves from operating execution to legal overhang.